The Study
Baseline surveillance in Li Fraumeni syndrome using whole-body MRI: a systematic review and updated meta-analysis
This study found that when doctors use whole-body MRI scans on people with Li-Fraumeni syndrome, they often find early signs of cancer. But it doesn’t prove the scans save lives — just that they find more problems early.
Analysis score
Maximum 100 for a systematic review with meta-analysis.
Where the score came from
This study looked at people born with a broken gene (TP53) that makes them very likely to get cancer young. Doctors used full-body MRI scans to find tumors before symptoms appeared.
Where does this study sit?
Systematic Reviews & Meta-analyses
Max 100Randomized Trials
Max 90Cohort Studies
Max 72Case-Control
Max 58Cross-Sectional
Max 44Case Reports & Series
Max 30Expert Opinion
Max 542 / 100
Quality score
The highest quality evidence. These studies systematically search, appraise, and synthesize results from multiple individual studies, providing the most reliable summary of current knowledge.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — finding 41 out of 46 cancers early means many could be treated before they become deadly.
- 231% had weird spots on scans; 6% had cancer found early; 18% of weird spots turned out to be cancer; 2% got new cancer each time they got scanned.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
European Radiology
Year
2024
Authors
M. I. Dacoregio, P. C. Abrahão Reis, Davi Said Gonçalves Celso, L. Romero, Stephan Altmayer, M. Vilbert, F. Y. Moraes, Israel Gomy
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.